Whole Genome And Exome Sequencing Markets, 2023 by Research, Clinical, Direct to Consumer, AgriBio & Tumor
Dublin, Jan. 25, 2021 (GLOBE NEWSWIRE) -- The "Whole Genome And Exome Sequencing Markets - By Research, Clinical, Direct to Consumer, AgriBio & Tumor with Executive and Consultant Guides 2020 to 2024" report has been added to ResearchAndMarkets.com's offering.
Will all newborns receive Whole Genome Sequencing at birth? How fast will Direct to Consumer Testing grow? What sequencing technology will take the lead? What's holding the industry back? Where are the over 800 locations that have high throughput devices?
A plummeting of costs for Whole Genome Sequencing is creating a gold rush for market players. New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well-funded players are racing for market share on a truly global stage. The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions.
Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
Highlights
The research makes you the expert in your organization.
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
Key Topics Covered:
1. Introduction and Market Definition
1.1 Whole Genome Sequencing Definition In This Report
1.1.1 Whole and Exome Sequencing
1.1.2 Research and Clinical
1.1.3 Direct to Consumer
1.1.4 AgriBio
1.1.5 Tumor Cells
1.2 The Genomics Revolution
1.3 Market Definition
1.3.1 Revenue Market Size
1.4 U.S. Medical Market and laboratory Testing - Perspective
1.4.1 U.S. Medicare Expenditures for laboratory testing
1.5 Sizing the Genome - Not What You Think
1.5.1 Cost, Price and Genome Size, Pricing Practice
2. Market Overview
2.1 Market Participants Play Different Roles
2.1.1 Instrument Manufacturer
2.1.2 Independent lab specialized/esoteric
2.1.3 Independent lab national/regional
2.1.4 Independent lab analytical
2.1.5 Public National/regional lab
2.1.6 Hospital lab
2.1.7 Physician lab
2.1.8 DTC Lab
2.1.9 Sequencing Labs
2.1.10 Audit body
2.2 Whole Genome Sequencing -Markets, Examples and Discussion
2.2.1 Direct to Consumer - Two Approaches
2.2.1.1 The New Age of Medical Information
2.2.1.2 Dangers in DTC-WGS - Health Costs and Regulation
2.2.1.3 Newborn and Prenatal - A Brave New World
2.2.1.4 DTC - How Many Segments?
2.2.2 Research Markets
2.2.2.1 Research Funding and Capital Expense
2.2.2.2 WGS Datasets Preferred
2.2.2.3 Existing research repurposed
2.2.2.4 Organism Wide Market
2.2.2.5 Service Suppliers Respond
2.2.3 Clinical - Understanding Germline and Somatic
2.2.3.1 Somatic - Chasing Mutations and Pharmacogenomics
2.2.4 Pathogen Testing
2.2.4.1 The Hepatitis C Story
2.2.4.2 Will the Microbiology Department Disappear?
2.2.5 AgriBio - Big Business
2.2.5.1 GMO is Here to Stay
2.2.5.2 WGS Benefits and Risks
2.2.5.3 The New Agriculture
2.3 Industry Structure
2.3.1 Hospital's Testing Share
2.3.2 Economies of Scale
2.3.3 Instrument Manufacturer Role
2.3.4 Healthcare Industry Impacts - Still Struggling
2.3.4.1 Can the Healthcare Industry Adapt?
2.3.4.2 Genetic Counselling as an Industry
2.3.4.3 WGES Adoption and Cannibalization
2.3.4.4 The Meaning of Grail
3. Market Trends
3.1 Factors Driving Growth
3.1.1 Diagnostic Factors
3.1.2 Interpreting the Code Otherwise
3.1.3 Changes in Agriculture.
3.1.4 Fertility Technology Comes of Age
3.1.5 Pathogen Challenges
3.2 Factors Limiting Growth
3.2.1 Increased Competition Lowers Price
3.2.2 Lower Costs
3.2.3 Healthcare Cost Concerns Curtail Growth
3.2.4 Wellness has a downside
3.2.5 GMO Opposition Movement.
3.3 Sequencing Instrumentation
3.3.1 Instrumentation Tenacity.
3.3.2 Declining Cost of Instruments Changes Industry Structure.
3.3.3 LISTING of CURRENT NGS INSTRUMENT SPECIFICATIONS.
3.3.4 Oxford Nanopore
3.3.4.1 What is Oxford Nanopore Sequencing?
3.3.4.2 What can Oxford Nanopore Sequencingt be used for?
3.3.4.3 Oxford Nanopore Products
3.3.5 Long Reads - Further Segmentation
3.3.6 Linked Reads
3.3.7 Targeted Sequencing Adopts CRISPR
3.3.8 New Sequencing Technologies
4. WGES Recent Developments
4.1 Recent Developments - Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section
UK Whole-Genome Sequencing Project Obtains 200M
WGS may help with disease outbreaks
Veritas Cuts WGS Price by 40%
Dante Labs Launches GenomeL, Long Reads Human Whole Genome Sequencing
Machine-learning system used to diagnose genetic diseases
Whole Genome Sequencing for healthy creates controversy
100,000 whole genomes sequenced in the NHS
Nebula Genomics Offers FREE Whole Genome Sequencing
Veritas Genetics has time limited WGS offer for $199
Veritas Genetics Launches Two New Whole Genome Sequencing Products
BGI unveils a powerful new sequencer
State of California Funds $2M Whole-Genome Sequencing Pilot
Rapid genome sequencing could revolutionize health care
Human Longevity Launches Whole Genome Product, MassMutual Partnerships
$1500 to sequence newborns in China
Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion
PerkinElmer Launches Clinical Whole Genome Sequencing Services
Nine Centres use Oxford Nanopore MinION to Sequence Human Genome
Esperite and BGI Genomics sign a strategic agreement to offer Whole Genome
Sequencing on a large scale
Easily Affordable Whole-genome Sequencing is Goal of Mayo Collaboration with Veritas
Regeneron Partners With AbbVie, Alnylam, AstraZeneca, Biogen, Pfizer to Sequence UK
Biobank Samples
MedGenome Expands Its NGS Capabilities and Forays Into Single-Cell Sequencing
Genomics England Adopts Edico's Dragen For NGS Analysis
BGI Says It Will Slash Cost of Gene Testing to $300
Position Statement Spells Out Fetal Diagnostic Sequencing Recommendations
Dante Labs Announces 10,000 European Genome Project
5. Profiles of Key Companies
10x Genomics, Inc
23andME Inc
Abbott Diagnostics
AccuraGen Inc.
Adaptive Biotechnologies
Admera Health, LLC
Agena Bioscience, Inc
Agilent
Akonni Biosystems
Ancestry.com LLC
Anchor Dx
ArcherDx, Inc
ARUP Laboratories
Asuragen
Baylor Miraca Genetics Laboratories
Beckman Coulter, Inc
Becton, Dickinson and Company
BGI Genomics Co. Ltd
Bioarray Genetics
Biocept, Inc
Biodesix Inc.
BioFluidica
BioGenex
Biolidics Ltd
bioMerieux Diagnostics
Bioneer Corporation
Bio-Rad Laboratories, Inc.
Bio-Techne
Cancer Genetics
Caris Molecular Diagnostics
CellMax Life
Centogene
Chronix Biomedical
Circulogene
Clinical Genomics
Color Genomics
Complete Genomics, Inc. - A BGI Company
Cynvenio
Dante Labs
Datar Cancer Genetics Limited
Diasorin S.p.A
Epic Sciences
Epigenomics AG
Eurofins Scientific
Excellerate Bioscience
Exosome Diagnostics
Fabric Genomics
Fluidigm Corp
Foundation Medicine
Freenome
FUJIFILM Wako Diagnostics
Fujirebio
GE Global Research
GE Healthcare Life Sciences
Gene by Gene, Ltd
Genedrive
GeneFirst Ltd
Genetron Health (Beijing) Co., Ltd.
Genewiz
Genomic Health
Genomics England
Genomics Personalized Health (GPH)
GenomOncology
Genzyme Corporation
Grail, Inc
Grifols
Guardant Health
Guardiome
HeiScreen
Helix
Helomics
Hologic
Horizon Discovery
HTG Molecular Diagnostics
Human Longevity, Inc
iCellate
Illumina
Incell Dx
Inivata
Integrated Diagnostics
Invitae Corporation
Invivoscribe
Karius
Macrogen
MDNA Life SCIENCES, Inc
MDx Health
Medgenome
Meridian Bioscience
Mesa Biotech
MIODx
miR Scientific
MNG Labs
Molecular MD
NantHealth, Inc.
Natera
Nebula Genomics
NeoGenomics
New Oncology
Novogene Bioinformatics Technology Co., Ltd
Omega Bioservices
OncoDNA
ORIG3N, Inc
Origene Technologies
Oxford Nanopore Technologies
Pacific Biosciences
Panagene
Perkin Elmer
Personal Genome Diagnostics
Personalis
Precipio
PrecisionMed
Promega
Protagen Diagnostics
Qiagen Gmbh
Quantumdx
Regeneron
Roche Molecular Diagnostics
Roswell Biotechnologies
Seegene
Sequencing.com
Siemens Healthineers
simfo GmbH
Singlera Genomics Inc
SkylineDx
Stratos Genomics
Sure Genomics, Inc
Sysmex
Sysmex Inostics
Tempus Labs, Inc
Thermo Fisher Scientific Inc
Veritas Genetics
Volition
6. Global Market Size
6.1 Global Market by Country
6.2 Global Market by Application
7. Market Sizes by Application
7.1 Research Market
7.2 Clinical Market
7.3 Tumor Market
7.4 DTC WEGS Market
7.5 Agribio & Other Market
8. Market Sizes by Coverage
8.1 Genome Market
8.2 Exome Market
8.3 Other Coverage Market
9. Vision of the Future of Whole Genome Sequencing
Appendices
For more information about this report visit https://www.researchandmarkets.com/r/j73khq
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900